Smith & Nephew (SNN) Depreciation & Amortization (CF) (2009 - 2024)
Smith & Nephew (SNN) reported Depreciation & Amortization (CF) of $273.0 million for Q4 2024, down 4.55% on a YoY basis from $286.0 million in Q1 2024, and down 4.55% quarter-over-quarter from $286.0 million in Q4 2023.
Smith & Nephew (SNN) Depreciation & Amortization (CF) (2009 - 2024) Analysis & Trends
Smith & Nephew has reported Depreciation & Amortization (CF) for 15 years, with the latest figure at $273.0 million in Q4 2024.
- For the quarter ending Q4 2024, Depreciation & Amortization (CF) fell 4.55% year-over-year to $273.0 million; the trailing twelve-month figure through Dec 2025 stood at $273.0 million (down 68.55% YoY), and the FY2025 full-year result was $239.0 million, down 62.95% from the prior year.
- Depreciation & Amortization (CF) for Q4 2024 stood at $273.0 million, down from $286.0 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $309.0 million in Q4 2022, with the low at $271.0 million in Q4 2020.
- Historically, Depreciation & Amortization (CF) has averaged $286.6 million across 5 years, with a median of $286.0 million in 2023.
- Annual changes were most pronounced in 2020 — Depreciation & Amortization (CF) slumped 47.68% — and 2021, when it increased 8.49%.
- Smith & Nephew's Depreciation & Amortization (CF) stood at $271.0 million in 2020, then increased by 8.49% to $294.0 million in 2021, then rose by 5.1% to $309.0 million in 2022, then slipped by 7.44% to $286.0 million in 2023, then decreased by 4.55% to $273.0 million in 2024.
- The last three Depreciation & Amortization (CF) figures came in at $273.0 million (Q4 2024), $286.0 million (Q4 2023), and $309.0 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Smith & Nephew | 5.27 Bn | 4.69 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 273.00 Mn |
| Dec 31, 2024 | 273.00 Mn |
| Dec 31, 2023 | 286.00 Mn |
| Dec 31, 2023 | 286.00 Mn |
| Dec 31, 2022 | 309.00 Mn |
| Dec 31, 2022 | 309.00 Mn |
| Dec 31, 2021 | 294.00 Mn |
| Dec 31, 2021 | 294.00 Mn |
| Dec 31, 2020 | 271.00 Mn |
| Dec 31, 2020 | 271.00 Mn |
| Dec 31, 2019 | 518.00 Mn |
| Dec 31, 2019 | 518.00 Mn |
| Dec 31, 2018 | 454.00 Mn |
| Dec 31, 2018 | 454.00 Mn |
| Dec 31, 2017 | 460.00 Mn |
| Dec 31, 2017 | 460.00 Mn |
| Dec 31, 2016 | 478.00 Mn |
| Dec 31, 2016 | 478.00 Mn |
| Dec 31, 2015 | 511.00 Mn |
| Dec 31, 2015 | 511.00 Mn |